Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX0AHY
|
||||
| Drug Name |
1-(4-fluoro-3-(trifluoromethyl)phenyl)-3-(3-(8-(pyridin-4-ylmethylamino)imidazo[1,2-a]pyrazin-6-yl)phenyl)urea
|
||||
| Synonyms |
CHEMBL1081740
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C26H19F4N7O
|
||||
| Canonical SMILES |
Fc1ccc(NC(=O)Nc2cccc(c2)c3cn4ccnc4c(NCc5ccncc5)n3)cc1C(F)(F)F
|
||||
| InChI |
InChI=1S/C26H19F4N7O/c27-21-5-4-19(13-20(21)26(28,29)30)35-25(38)34-18-3-1-2-17(12-18)22-15-37-11-10-32-24(37)23(36-22)33-14-16-6-8-31-9-7-16/h1-13,15H,14H2,(H,33,36)(H2,34,35,38)
|
||||
| InChIKey |
ZNDXPRCORYDEAP-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Vascular endothelial growth factor receptor 2 | Target Info | [1587926] | ||
| Angiopoietin 1 receptor | Target Info | [1587926] | |||
| NetPath Pathway | IL2 Signaling PathwayNetPath_8:Wnt Signaling Pathway | ||||
| PANTHER Pathway | Angiogenesis | ||||
| VEGF signaling pathwayP00005:Angiogenesis | |||||
| Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
| Beta3 integrin cell surface interactions | |||||
| Signaling events mediated by TCPTP | |||||
| SHP2 signaling | |||||
| S1P1 pathway | |||||
| VEGF and VEGFR signaling network | |||||
| Integrins in angiogenesis | |||||
| Signaling events mediated by VEGFR1 and VEGFR2 | |||||
| Notch-mediated HES/HEY networkangiopoietinreceptor_pathway:Angiopoietin receptor Tie2-mediated signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.